Skip to content

Ardelyx ARDX Operating margin

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
5.6%-10.3pp
AbbVie logo
AbbVieABBV
24.4%
XER
Xeris Biopharma Holdings, Inc.XERS
11.4%+7.7pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
25.4%+4.9pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
41.7%+29.4pp

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on trailing twelve months.

The official record: Ardelyx’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's operating margin?
Ardelyx (ARDX) reported operating margin of -25.4% in Q3 2024.
What is the long-term trend for Ardelyx's operating margin?
Over 2 years (2020 to 2023), Ardelyx's operating margin has grown at a -79.4% compound annual growth rate (CAGR), from -1,199% to -50.8%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.